Abstract
IntroductionThe GLOBAL LEADERS is an open-label, pragmatic and superiority randomised controlled trial designed to challenge the current treatment paradigm of dual antiplatelet therapy (DAPT) for 12 months followed by aspirin...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have